From: Neo-adjuvant chemo-radiation of rectal cancer with Volumetric Modulated Arc Therapy: summary of technical and dosimetric features and early clinical experience
RA
3DC
Erithema
G1/G2
28%(7/25)
15% (3/20)
G3/G4
0% (0/25)
0%(0/20)
Diarrhoea
40% (10/25)
45% (9/20)
8% (2/25)
5% (1/20)
Disuria/incontinency
10%(2/20)
0%(0/25)
0% (0/20)